Biotechnology double deals...
Little old Betaville has noticed that three of the world's largest pharmaceutical giants have all recently done two major takeover deals within a few weeks, and in some cases days, of each other...
Little old Betaville has noticed that three of the world's largest pharmaceutical giants have all recently done two major takeover deals within a few weeks, and in some cases days, of each other...
Abbvie has announced the $8.7 billion acquisition of US-listed Cerevel Therapeutics, marking its second multi-billion dollar second acquisition in the space of week.
Now, I have to admit little old Betaville is in a bit of grump about this deal announcement as I had been chasing down this story down over the last 24 hours. Grrrrrr...
Abbvie has just announced it has bought ImmunoGen, Inc for $10.1 billion in cash. Below is a link to the press release: